Introduction
Both the obstetrician and the laboring woman would like to accomplish the delivery in the shortest possible time without compromising the maternal and fetal safety. Hence, along with early amniotomy and early administration of oxytocin, to accelerate labor many advise the use of antispasmodic agents like drotaverine, hyoscine butylbromide, dicyclomine valethamide bromide etc. to hasten the first stage of labor [1] . Among these drugs we selected two drugs drotaverine hydrochloride (DH) and valethamate bromide (VB) to compare their efficacy in accelerating the rate of cervical dilatation.
DH is an isoquinoline derivative and its chemical name is 3, 4, 6, 7 tetraethoxy-1 benzyl 1, 2, 3, 4 tetrahydro isoquinoline hydrochloride [2] . It is an unique smooth muscle relaxant and acts by inhibiting phosphodiesterase-IV enzyme that results in increased cAMP [3] . VB is an anticholinergic smooth muscle relaxant. It is an ester with chemical name ethanaminium N, N -diethyl N-methyl 2(3 methyl-1-oxo-2 phenyl pentyl) bromide. It acts by competitively inhibiting the muscarinic receptors of smooth muscle cells followed by inhibition of phospholipase C and decreases intracellular calcium [4, 5] .
The effects of DH and VB have superiority over other smooth muscle relaxants routinely used in clinical practice, easy available even in rural setup, cheap and have no proven adverse effects on mothers, foetuses and the new born.
The objective of this study was to compare and evaluate the efficacies of DH and VB for effective cervical dilatation in first stage of labour.
Material and methods

Study design
The study was conducted in Santhiram General Hospital, Nandyal over a period of 1½ 
Evaluation criteria
After considering inclusion criteria and after taking informed consent, patient was examined in detail at 80% effacement and 3-4 cm cervical dilatation with adequate uterine contractions. The drug was given intravenously. These patients were monitored for vital data, rate of cervical dilatation, injection dilatation interval, mode of delivery, duration of second and third stages of labour, neonatal outcome, side effects to drug and patient's satisfaction regarding pain reduction
2.4.Statistical analysis
The results were tabulated and analysed. SPSS for Windows Version 10.0 (SPSS Inc., USA) was used for the statistical analysis. The Chi square/and the Fisher's exact tests of significance were used wherever they were applicable and P -values less than or equal to 0.05 were considered significant.
Results
We studied 100 patients in first stage of labour with 50 patients each in drotaverine (D) and valethamate (V) groups including both primigravidae and multigravidae. The age distribution in both groups is comparable i.e. between 20 to 30 years.
Effect of DH and VB on different stages of labour
As observed in table 1, in primigravidae for D group , 14% of patients had active stage duration of <2 hours , 63% of them had [2] [3] [4] hours and 23% of patients had [4] [5] [6] hours. In secondgravidae of D group , 21% of patients had duration of active phase of <2 hours, 73% of them had duration of [2] [3] [4] hours, and in 6% of secondgravidae the duration of active phase was [4] [5] [6] hours. While in 55% of thirdgravidae the duration of active phase was <2 hours and 45% of them had duration of active phase of [2] [3] [4] hours .
In primigravidae of V group, 4% of patients had the duration of active phase of <2 hours, 26% of them had the duration of 2-4 hours, and in 67% of primigravidae the duration was 4-6 hours. In remaining 3% of primigravidae the duration of active phase was [6] [7] [8] hours. In Secondgravida of V-group, 17% of preganant women showed the duration of active phase to be <2 hours, 42% of them had the duration of active phase of [2] [3] [4] hours and in 41% of pregnant women h the duration was [4] [5] [6] hours. Where as in thirdgravida of V group, 27% of them had the duration of <2 hours and 73% patients showed the duration of active phase to be 2-4 hours (Table 1) .
D-group: with respect to second stage of labor , 17%, 78% (Table 2) . V-group: regarding second stage of labor, 9%, 81% and 10% of primigravidae had the duration of second stage of < ½ hour, ½ -1 hour and 1 -2 hours respectively . where as 65% and 35% of secondgravidae , the duration of second stage showed were < ½ hour and ½ -1 hour respectively . Additionally, in 64% and 36% of thirdgravidae the duration of second stage in V-Group is < ½ hour and ½ -1 hour (Table 2) . With reference to third stage of labor, in 90% and 10 % of primigravidae the duration of third stage were 0-10 minutes and 10-20 minutes respectively. While in 94% and 6% of secondgravidae the duration of third stage were 0-10 minutes and 10-20 minutes correspondingly. Further in 100% of thirdgravidae the duration of third stage was 0-10 minutes (Table 2 ).
Apgar scores of neonates in D-group and V group
With reference to APGAR score for D group , 92% and 8% of primigravidae had a score of 8-10 and 6-8 respectively. While 100% of secondgravidae and thirdgravidae patients had a score of [8] [9] [10] (Table 3 ) . The APGAR score in 86% and 14% of primigravidae in V group had 8-10 and 6-8 respectively. While 100% of secondgravidae and thirdgravidae of V-group had a score of [8] [9] [10] (Table 3) Figure 1 ). The total number of cases in primigravidae, secondgravidae and thirdgravidae in drotaverine group with injection dilatation interval less than 4 hours was significantly more than valethamate bromide group (P-value < 0.05 which is statistically significant.)
In drotaverine group the average duration of second stage is 39.5 minutes in primigravidae, 24.26 minutes (Table 5 and Table 6 ). (PPH) were noted in any group.
Discussion
The concept of active management of labour gained strength in clinical practice with the availability of cervical smooth muscle dilators. Drotaverine and valethamate are more frequently used by many institutes of obstetrics and foetal medicine.
In our study we evaluated and compared the effect of DH and VB on cervical dilatation, duration of second and third stages of labour and third stage complications. After intravenous(IV) administration the drotaverine is rapidly absorbed and has half life is 12 minutes, reaches maximum concentration in 45 minutes. The primary elimination half life is 2.4 hours. It doesn't cross placental barrier and metabolised by liver. It is excreted through urine and faeces as unchanged drug [6, 7] . After intravenous(IV) of valethamate action starts with in 5-10 minutes. Its Plasma half-life is 4 hours. It crosses the placental barrier and is also secreted in breast milk, but has no proven deleterious effects on foetus and baby. It is completely metabolised by liver and excreted in urine as both unchanged drug and metabolites [4, 5] The first stage of labour is longest and more painful especially in primigravidae. The smooth muscle content of cervix is 6 -25% that offers contractile response to the advancing foetal head. This provides the physiological basis to use smooth muscle relaxants. The administration of smooth muscle relaxants at an appropriate time and dilatation phase can reduce the duration of labour successfully while providing pain reduction.
Ever since Farkas et al (1967) [8] concluded that drotaverine effectively relieves the cervical smooth muscle spasm, many obstetricians used drotaverine for accelerating labour and proved it as an effective cervical dilator. Our study also proved the same.
In the study done by Sharma et al (2001) [9] with drotaverine and valethamate in acceleration of labour, he concluded that both are effective but drotaverine accelerated labour more rapidly with less side effects. The [10] it was proved that drotaverine is highly effective cervical dilating agent compared to valethamate and control groups.
The average duration of 3 cm to full cervical dilatation was 3 [12] they proved that both the drugs were effective in cervical dilatation but drotaverine hydrochloride is superior to valethamate bromide with less side effects.
In the present study the mean duration of active phase was 186.3 minutes (3 hours 6 minutes) with drotaverine and 254.2 minutes (4 hours 14 minutes) with valethamate in primigravidae and 140.76 minutes (2 hours 20 minutes) with drotaverine and 172.82 minutes (2 hours 52 minutes) with valethamate in multigravidae. The rate of cervical dilatation is 1.92 cm/hour and 2.58 cm/hour with drotaverine in primigravidae and multigravidae respectively whereas it is 1.44 cm/hour and 2.19 cm/hour with valethamate in primigravidae and multigravidae respectively. Both drotaverine and valethamate are effective in cervical dilatation but drotaverine is superior to valethamate. The data from the studies of J.B Sharma et al [9] , S.L Mishra et al [10] and C.Madhu et al [12] also support this findings.
In the present study there is no significant difference in the duration of second and third stages with both the drugs and no increase in obstetrical complications. This is supported by the studies done by Sharma et al [9] , Anju et al [13] and C. Madhu et al [12] . Some obstetricians have reserved opinions that the cervical spasmolytic action of drotaverine could weaken the uterine contractions thus delaying the progress of labour. However no scientific studies are available in defence of such opinions. But our study and previous studies proved that drotaverine hydrochloride had no such effect.
In our study 6% of cases in valethamate group experienced vomiting, tachycardia and dryness of mouth. In drotaverine group patients had no such complaints. Our findings are consistent with the findings of Anju et al [13] , S.L. Misra et al [10] and Monika et al [11] .
The APGAR scores were also not effected in both groups. Multigravidae expressed definite satisfaction with pain experience compared to their previous labour pains. This is more with drotaverine than valethamate. This comparison is not obtained in primigravidae as they have no such experiences of labour pains previously. The sum effect of reduction in total duration of labour reduced the maternal morbidity and did not adversely affect the foetal outcome. The process of labour as such becomes less anxious and less painful experience fulfilling the aim of the obstetrician and desire of the patient.
Both the drugs are easily available even in rural set up, less expensive, easy to administer, no need of anaesthetist and easy to monitor with less side effects.
Our study found an increasing role of drotaverine hydrochloride in reducing the total duration of labour, hastening cervical dilatation, ensuring smooth progress of labour with good maternal and foetal outcome. It is concluded that overall efficacy of drotaverine was superior than the valethamate bromide.
The drugs drotaverine and valethamate are in the practice of clinical obstetrics. Both the drugs effectively relieve the maternal pain by reducing the cervical contractile response and shorten the duration of labour. Drotaverine is found to be better than valethamate in shortening the duration of labour and gives better pain relief. But both the drugs had no major side effects. .
